UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dasatinib suppresses atherosclerotic lesions by suppressing cholesterol uptake in a mouse model of hypercholesterolemia

Journal of pharmacological sciences, 2022-07, Vol.149 (3), p.158-165

2022

Volltextzugriff (PDF)

Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group

International journal of hematology, 2020-09, Vol.112 (3), p.409-417

2020

Volltextzugriff (PDF)

Clinical outcomes of second‐generation tyrosine kinase inhibitors versus imatinib in older patients with CML

Cancer science, 2023-03, Vol.114 (3), p.995-1006

2023

Volltextzugriff (PDF)

Prognostic effect of comorbidities in patients with chronic myeloid leukemia treated with a tyrosine kinase inhibitor

Cancer science, 2020-10, Vol.111 (10), p.3714-3725

2020

Volltextzugriff (PDF)

Polaprezinc for prevention of oral mucositis in patients receiving chemotherapy followed by hematopoietic stem cell transplantation: A multi‐institutional randomized controlled trial

International journal of cancer, 2021-03, Vol.148 (6), p.1462-1469

2021

Volltextzugriff (PDF)

Characterization of endogenous markers of hepatic function in patients receiving itraconazole treatment for prophylaxis of deep mycosis

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023-03, Vol.29 (3), p.244-249

2023

Volltextzugriff (PDF)

PB1961: INVOLVEMENT OF IMMUNITY IN THE CONTINUATION OF TFR AFTER BOSTINIB DISCONTINUATION

HemaSphere, 2023-08, Vol.7 (S3), p.e3071774-n/a

2023

Volltextzugriff (PDF)

Associations between plasma hydroxylated metabolite of itraconazole and serum creatinine in patients with a hematopoietic or immune-related disorder

European journal of clinical pharmacology, 2021-03, Vol.77 (3), p.369-379

2021

Volltextzugriff (PDF)

Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia

International journal of hematology, 2020-07, Vol.112 (1), p.24-32

2020

Volltextzugriff (PDF)

Bosutinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia: final 3-year follow-up results of a phase 2 study

International journal of hematology, 2022-12, Vol.116 (6), p.871-882

2022

Volltextzugriff (PDF)

A simple method to distinguish residual elotuzumab from monoclonal paraprotein in immunofixation assays for multiple myeloma patients

International journal of hematology, 2021-04, Vol.113 (4), p.473-479

2021

Volltextzugriff (PDF)

Identification of skin‐infiltrating donor lymphocytes in a case of pre‐engraftment syndrome

Journal of dermatology, 2023-09, Vol.50 (9), p.e282-e284

2023

Volltextzugriff (PDF)

Prognostic impact of the dosage of methotrexate combined with tacrolimus for graft-versus-host disease prophylaxis after cord blood transplantation

International journal of hematology, 2021-08, Vol.114 (2), p.252-262

2021

Volltextzugriff (PDF)

Which Tyrosine Kinase Inhibitors Should Be Selected as the First-Line Treatment for Chronic Myelogenous Leukemia in Chronic Phase?

Cancers, 2021-10, Vol.13 (20), p.5116

Ono, Takaaki

2021

Volltextzugriff (PDF)

Safety profile of bosutinib in Japanese versus non-Japanese patients with chronic myeloid leukemia: a pooled analysis

International journal of hematology, 2022-06, Vol.115 (6), p.838-851

2022

Volltextzugriff (PDF)

Degradation Analysis of Oxide-Based All-Solid-State Na Batteries by Operando Raman Spectroscopy

ACS applied energy materials, 2023-06, Vol.6 (11), p.6194-6200

2023

Volltextzugriff (PDF)

Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial

International journal of hematology, 2022, Vol.115 (1), p.33-42

2022

Volltextzugriff (PDF)

Cardiotoxicity of Carfilzomib in Two Japanese Patients with Relapsed Multiple Myeloma

Internal Medicine, 2019/06/01, Vol.58(11), pp.1577-1581

2019

Volltextzugriff (PDF)

Magnetically Levitated Turbomolecular Pump

Seimitsu Kōgakkaishi, 2023-11, Vol.89 (11), p.804-807

ONO, Takaaki

2023

Volltextzugriff (PDF)

Discovery of unique African Helicobacter pylori CagA-multimerization motif in the Dominican Republic

World journal of gastroenterology : WJG, 2020-12, Vol.26 (45), p.7118-7130

2020

Volltextzugriff (PDF)

A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline Treatment

Clinics and practice, 2024-06, Vol.14 (4), p.1216-1224

2024

Volltextzugriff (PDF)

Comparative study between Helicobacter pylori and host human genetics in the Dominican Republic

BMC ecology and evolution, 2019-11, Vol.19 (1), p.197, Article 197

2019

Volltextzugriff (PDF)

Nilotinib Vs. Dasatinib in Achieving MR4.5 for Newly Diagnosed Chronic Myeloid Leukemia: Results of the Prospective Randomized Phase 3 Study, JALSG CML212

Blood, 2020-11, Vol.136 (Supplement 1), p.40-41

2020

Volltextzugriff (PDF)

Serum IgM levels independently predict immune response to influenza vaccine in long-term survivors vaccinated at >1 year after undergoing allogeneic hematopoietic stem cell transplantation

International journal of hematology, 2017-05, Vol.105 (5), p.638-645

2017

Volltextzugriff (PDF)

1 – 25 von 617

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(475)
Mit Volltextzugriff
(525)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Dasatinib suppresses atherosclerotic lesions by suppressing cholesterol uptake in a mouse model of hypercholesterolemia

Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group

Clinical outcomes of second‐generation tyrosine kinase inhibitors versus imatinib in older patients with CML

Prognostic effect of comorbidities in patients with chronic myeloid leukemia treated with a tyrosine kinase inhibitor

Polaprezinc for prevention of oral mucositis in patients receiving chemotherapy followed by hematopoietic stem cell transplantation: A multi‐institutional randomized controlled trial

Characterization of endogenous markers of hepatic function in patients receiving itraconazole treatment for prophylaxis of deep mycosis

PB1961: INVOLVEMENT OF IMMUNITY IN THE CONTINUATION OF TFR AFTER BOSTINIB DISCONTINUATION

Associations between plasma hydroxylated metabolite of itraconazole and serum creatinine in patients with a hematopoietic or immune-related disorder

Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia

Bosutinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia: final 3-year follow-up results of a phase 2 study

A simple method to distinguish residual elotuzumab from monoclonal paraprotein in immunofixation assays for multiple myeloma patients

Identification of skin‐infiltrating donor lymphocytes in a case of pre‐engraftment syndrome

Prognostic impact of the dosage of methotrexate combined with tacrolimus for graft-versus-host disease prophylaxis after cord blood transplantation

Which Tyrosine Kinase Inhibitors Should Be Selected as the First-Line Treatment for Chronic Myelogenous Leukemia in Chronic Phase?

Safety profile of bosutinib in Japanese versus non-Japanese patients with chronic myeloid leukemia: a pooled analysis

Degradation Analysis of Oxide-Based All-Solid-State Na Batteries by Operando Raman Spectroscopy

Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial

Cardiotoxicity of Carfilzomib in Two Japanese Patients with Relapsed Multiple Myeloma

Magnetically Levitated Turbomolecular Pump

Clinical utility of genomic profiling of AML using paraffin‐embedded bone marrow clots: HM‐SCREEN‐Japan 01

Discovery of unique African Helicobacter pylori CagA-multimerization motif in the Dominican Republic

A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline Treatment

Comparative study between Helicobacter pylori and host human genetics in the Dominican Republic

Nilotinib Vs. Dasatinib in Achieving MR4.5 for Newly Diagnosed Chronic Myeloid Leukemia: Results of the Prospective Randomized Phase 3 Study, JALSG CML212

Serum IgM levels independently predict immune response to influenza vaccine in long-term survivors vaccinated at >1 year after undergoing allogeneic hematopoietic stem cell transplantation

Suchergebnisse filtern